Product Name

  • Name

    AZASERINE

  • EINECS
  • CAS No. 115-02-6
  • Article Data3
  • CAS DataBase
  • Density g/cm3
  • Solubility
  • Melting Point 146-162° (dec)
  • Formula C5H7 N3 O4
  • Boiling Point °Cat760mmHg
  • Molecular Weight 173.128
  • Flash Point °C
  • Transport Information
  • Appearance
  • Safety Suspected carcinogen with experimental carcinogenic, neoplastigenic, and tumorigenic data. Poison by ingestion, intraperitoneal, and subcutaneous routes. An experimental teratogen. Other experimental reproductive effects. Human mutation data reported. When heated to decomposition it emits toxic fumes of NOx.
  • Risk Codes 25-40
  • Molecular Structure Molecular Structure of 115-02-6 (AZASERINE)
  • Hazard Symbols
  • Synonyms L-Serine,diazoacetate (ester) (9CI); Serine, diazoacetate (ester), L- (6CI,8CI);Azaserin; Azaserine; CI 337; CN 15757; L-Azaserine; NSC 742;O-Diazoacetyl-L-serine; P 165
  • PSA 127.01000
  • LogP -0.97654

Azaserine Chemical Properties

Molecular Formula: C5H7N3O4
Molar mass: 173.13 g/mol
EINECS: 204-061-6
Storage temp: 2-8°C
Appearance: Pale yellow to green crystals
Solubility: H2O: 50 mg/mL, clear, yellow
Form: Lyophilized powder
Structure of Azaserine (115-02-6):

XLogP3-AA: -2
H-Bond Donor: 2
H-Bond Acceptor: 6
Systematic Name: 2-Amino-3-(2-diazoacetyl)oxy-propanoic acid 
SMILES: O=C(OCC(N)C(O)=O)\C=[N+]=[N-] 
InChI: InChI=1/C5H7N3O4/c6-3(5(10)11)2-12-4(9)1-8-7/h1,3H,2,6H2,(H,10,11) 
InChIKey: MZZGOOYMKKIOOX-UHFFFAOYAY 
Std. InChI: InChI=1S/C5H7N3O4/c6-3(5(10)11)2-12-4(9)1-8-7/h1,3H,2,6H2,(H,10,11) 
Std. InChIKey: MZZGOOYMKKIOOX-UHFFFAOYSA-N

Azaserine Uses

 Azaserine (115-02-6) is a carcinogen primarily used for researching pancreatic cancer in animal models.

Azaserine Toxicity Data With Reference

1.    

mma-sat 200 ng/plate

    PNASA6    Proceedings of the National Academy of Sciences of the United States of America. 72 (1975),5135.
2.    

mmo-bcs 500 µmol/L

    EXPEAM    Experientia. 39 (1983),530.
3.    

orl-rat LD50:170 mg/kg

    CANCAR    Cancer. 10 (1957),889.
4.    

ipr-rat LD50:70 mg/kg

    PSEBAA    Proceedings of the Society for Experimental Biology and Medicine. 94 (1957),27.
5.    

orl-mus LD50:150 mg/kg

    CANCAR    Cancer. 10 (1957),889.
6.    

ipr-mus LD50:100 mg/kg

    CANCAR    Cancer. 10 (1957),889.
7.    

scu-mus LD50:50 mg/kg

    85GDA2    CRC Handbook of Antibiotic Compounds, Volumes 1-9. 4 (1)(1980),432.
8.    

ivn-mus LD50:62 mg/kg

    85ERAY    Antibiotics: Origin, Nature, and Properties. 2 (1978),1249.
9.    

ivn-dog LDLo:30 mg/kg

    TXAPA9    Toxicology and Applied Pharmacology. 22 (1972),595.

Azaserine Consensus Reports

IARC Cancer Review: Group 2B IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 7 (1987),p. 56.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) ; Animal Limited Evidence IMEMDT    IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 10 (1976),p. 73.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) . EPA Genetic Toxicology Program.

Azaserine Safety Profile

Suspected carcinogen with experimental carcinogenic, neoplastigenic, and tumorigenic data. Poison by ingestion, intraperitoneal, and subcutaneous routes. An experimental teratogen. Other experimental reproductive effects. Human mutation data reported. When heated to decomposition it emits toxic fumes of NOx.
 

Hazard Codes: T
Risk Statements:
25:  Toxic if swallowed
40:  Limited evidence of a carcinogenic effect
Safety Statements:
36:  Wear suitable protective clothing 
37:  Wear suitable gloves
39:  Wear eye/face protection
45:  In case of accident or if you feel unwell, seek medical advice immediately (show label where possible)
53:  Avoid exposure - obtain special instruction before use

Azaserine Specification

 Azaserine (115-02-6)  is a glutamine analogue that irreversibly inhibits Gln: Phosphoribosyl Amidotransferase, which is involved in the biosynthesis of Inosine monophosphate (IMP), and also can be called O-Diazoacetyl-L-serine ; L-azaserine ; O-succinyl-L-homoserine and Serine, diazoacetate (ester) .

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View